Vera Therapeutics, Inc. — Director's Dealing 2021

Dec 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-12-10

Reporting Person: Hall Kimball (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-10	Stock Option (right to buy)	$24.36	A	19850	Acquired	2031-12-09	Class A Common Stock (19850)	Direct

Footnotes

F1: The shares subject to the option will vest monthly over a three-year period, subject to the reporting person's continuous service on each vesting date.